News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
November, 2024
November 2024
M T W T F S S
 123
45678910
11121314151617
18192021222324
252627282930  
Lucjan Wyrwicz: Proud to be the senior author of this important study…
Lucjan Wyrwicz/swiatlekarza.pl
Sep 19, 2023, 18:34

Lucjan Wyrwicz: Proud to be the senior author of this important study…

Lucjan Wyrwicz, medical oncologist from Maria Curie National Cancer Research Institute in Warsaw, Poland, recently shared on LinkedIn:

“Immunotherapy is an important innovation in treatment of advanced/metastatic gastric cancer (as well as esophageal adenocarcinoma and gastro-esophageal junction cancer). These malignancies combined are top-5 cancers worldwide. Recently we have shown that combination of immunotherapy and modern chemotherapy can prolong lifes of our patients (Checkmate-649 study). Today we report that such treatment will not negatively impact quality of life of these patients. Proud to be the senior author of this important study. Congratulations Markus Moehler and our co-authors!”

For the article click here.
Source: Lucjan Wyrwicz/Linkedin

cancer Checkmate-649 study esophageal adenocarcinoma gastric cancer immunotherapy Lucjan Wyrwicz Maria Curie National Cancer Research Institute Markus Moehler OncoDaily Oncology
Special Coverage
Blog
Nov 13, 2024, 11:30
ABC Global Alliance - Learning more about brain metastases in breast cancer
Blog
Nov 13, 2024, 11:25
Some information you should know about lung cancer - American Cancer Society
Insight
Nov 13, 2024, 11:10
Myeloma Paper of the Day, November 13th, suggested by Robert Orlowski
Blog
Nov 13, 2024, 11:01
LGCW2024 session on Galvanising African cancer research building a strong cancer workforce - AORTIC- Africa
Blog
Nov 13, 2024, 10:59
Bernard Fox received SITC lifetime achievement award
Blog
Nov 13, 2024, 10:54
Hear Her campaign Increasing awareness about lung cancer in women
Blog
Nov 13, 2024, 10:52
Johnson & Johnson Seeks Approval for DARZALEX FASPRO as Subcutaneous Monotherapy for High-Risk Smoldering Multiple Myeloma
Blog
Nov 13, 2024, 10:47
FDA approves obecabtagene autoleucel for relapsed or refractory B-cell precursor ALL
Blog
Nov 13, 2024, 10:45
OncoInfluencers to Follow on Social Media: Dr. Nitin Jain
Insight
Nov 13, 2024, 10:37
UCLA: Combination approach shows promise for treating rare, aggressive cancers
Opinion
Nov 13, 2024, 10:32
The 6th Biennial Miami Epigenetics and Cancer Symposium to be held in Sylvester Comprehensive Cancer Center
Blog
Nov 13, 2024, 10:16
Highlights from IU Simon Comprehensive Cancer Center’s End Lung Cancer Now Gathering - Hoosier Cancer Research Network